If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Block listing Interim Review

7 Jun 2018 16:23

RNS Number : 7019Q
MyCelx Technologies Corporation
07 June 2018
 

MyCelx Technologies Corporation

("MYCELX" or the "Company") (AIM: MYX)

 

7 June 2018

 

 

 

Block Admission Interim Update

 

In respect of the block admissions to trading on AIM on 29 April 2013 and 3 October 2017 for MYCELX common shares of US$0.025 each ("Shares"), MYCELX provides the following update in respect of the period 7 December 2017 to 6 June 2018 (the "Period").

 

 

Omnibus Performance Incentive Plan 2011 No of Shares

Admitted on 29 April 2013 300,000

Admitted on 3 October 2017 300,000

Issued prior to the Period (313,198)

Issued during the Period (20,000)

------------

Shares not yet issued 266,802

=======

 

 

 

 

Enquiries:

 

MYCELX Technologies Corporation +1 888 306 6843

Kimberly Slayton, Chief Financial Officer

 

Cantor Fitzgerald Europe

Nominated Adviser and Broker

David Porter

Richard Salmond +44 207 894 7000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRBUGDLGDGBGIR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS